阿片类药物耐受性 - - 在寻找圣杯的过程中
Brigitte L Kieffer1, Christopher J Evans
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France. briki@igbmc.u-strasbg.fr
Cell
|March 15, 2002
概括
阿片类药物耐受性,一种常见的适应疼痛药物,可以通过受体内化来减少,这挑战了受体脱敏化的传统观点. 这一发现为管理疼痛治疗提供了新的见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 对阿片类药物的耐受性是治疗慢性疼痛的一个重大挑战.
- 传统上,阿片类药物耐受性归因于阿片类受体脱敏化和细胞表面受体表达减少.
- 最近的研究表明,可能涉及其他替代机制.
研究的目的:
- 调查阿片类受体内化在阿片类耐药性发展中的作用.
- 挑战对阿片类药物耐受机制的既定理解.
主要方法:
- 这项研究可能涉及体内实验,以观察受体行为.
- 方法可能包括测量受体信号和细胞表面表达的技术.
- 对长期阿片类药物治疗的行为适应的分析.
主要成果:
- 有证据表明,受体内化可能会降低阿片类药物耐受性.
- 这与受体脱敏的传统解释形成鲜明对比.
结论:
- 片受体内部化可能是防止耐受性发展的保护机制.
- 这一发现需要重新评估阿片类药物耐受性背后的机制.
更多相关视频
相关概念视频
Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Drug Abuse and Addiction: Pharmacological Phenomena
1.7K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.7K
Opioid Receptors: Overview
7.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.4K
Analgesia and Pain Management
3.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.6K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.6K


